Business Context and Reporting Period
This Form 8-K Current Report was filed by Inogen, Inc. on September 9, 2019. The filing serves as a Regulation FD disclosure regarding the Company's participation in the Morgan Stanley Global Healthcare Conference in New York City, scheduled to begin on September 9, 2019, with a specific presentation by Company officers on September 11, 2019.
Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report is a disclosure of an upcoming investor event and does not contain a financial statement or quarterly results.
Material Changes
No material financial changes versus a prior comparable period are reported in this document. The filing notes that the Company will present updated information regarding 2018 Medicare data and the oxygen therapy market during the conference, but the specific figures are contained in the attached Exhibit 99.1 (Investor Presentation) rather than the text of the 8-K itself.
Guidance, Outlook, and Risks
Management commentary is limited to the announcement of the conference presentation. The Company intends to refer to an updated slide presentation containing market data. The filing includes a standard disclaimer stating that the information furnished, including the attached presentation, shall not be deemed "filed" for purposes of Section 18 of the Exchange Act and is not subject to the liabilities of that section, nor is it incorporated by reference into other filings except as expressly set forth.
Key Facts for Investor Verification
- Verify the specific 2018 Medicare data and oxygen therapy market updates by reviewing Exhibit 99.1 (Investor Presentation) attached to this filing.
- Confirm the live audio webcast availability on the Company's Investor Relations website at www.inogen.com.
- Note that the information in this 8-K and its exhibits is not deemed "filed" under Section 18 of the Exchange Act.